摘要
目的:研究分析抗肿瘤药伊立替康应用于临床治疗小细胞癌的效果。方法:选择40例小细胞癌患者,随机分为观察组与对照组,每组20例。观察组患者采用伊立替康联合顺铂治疗,对照组采用依托泊苷治疗,观察比较两组患者的治疗有效率及其不良反应情况。结果:观察组的治疗有效率显著高于对照组的治疗有效率(P<0.05);观察组的不良反应发生率小于对照组的不良反应发生率,差异有统计学意义(P<0.05)。结论:临床使用抗肿瘤药伊立替康联合顺铂治疗小细胞癌的疗效显著,且不良反应少,值得临床推广和应用。
Objective To study the analysis of antitumor drug,Irinotecan applied to clinical effect cell carcinoma.Methods Choose 40 cases for treatment of small cell carcinoma patients,randomly divided into observation group and control group,20 cases in each group,the control group treated with etoposide,look for the treatment of patients with two groups of efficient and its adverse reactions.Results The treatment group effectiveness is significantly higher than control group in treatment effectiveness（P〈0.05）.Conclusion The clinical use of anti-tumor drugs,Irinotecan combined cisplatin in less adverse reactions,worthy of clinical popularization and application.
出处
《吉林医学》
CAS
2014年第20期4422-4423,共2页
Jilin Medical Journal
关键词
抗肿瘤药
伊立替康
小细胞癌
Antineoplastic agent
Irinotecan
Small cell carcinoma
